{"id":"https://openalex.org/W4389537586","doi":"https://doi.org/10.1016/j.isci.2023.108711","title":"In situ modeling of acquired resistance to RTK/RAS-pathway-targeted therapies","display_name":"In situ modeling of acquired resistance to RTK/RAS-pathway-targeted therapies","publication_year":2023,"publication_date":"2023-12-11","ids":{"openalex":"https://openalex.org/W4389537586","doi":"https://doi.org/10.1016/j.isci.2023.108711","pmid":"https://pubmed.ncbi.nlm.nih.gov/36747633","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9901014"},"language":"en","primary_location":{"id":"doi:10.1016/j.isci.2023.108711","doi":"https://doi.org/10.1016/j.isci.2023.108711","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.isci.2023.108711","pdf_url":null,"source":{"id":"https://openalex.org/S2898358376","display_name":"iScience","issn_l":"2589-0042","issn":["2589-0042"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310315673","host_organization_name":"Cell Press","host_organization_lineage":["https://openalex.org/P4310315673","https://openalex.org/P4310320990"],"host_organization_lineage_names":["Cell Press","Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"iScience","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.isci.2023.108711","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055187581","display_name":"Nancy E. Sealover","orcid":"https://orcid.org/0000-0002-6463-5836","observed_orcids":["https://orcid.org/0000-0002-6463-5836"]},"institutions":[{"id":"https://openalex.org/I148314036","display_name":"Uniformed Services University of the Health Sciences","ror":"https://ror.org/04r3kq386","country_code":"US","type":"education","lineage":["https://openalex.org/I148314036"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy E. Sealover","raw_affiliation_strings":["Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA","institution_ids":["https://openalex.org/I148314036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078820052","display_name":"Patricia L. Theard","orcid":"https://orcid.org/0000-0001-9761-7645","observed_orcids":["https://orcid.org/0000-0001-9761-7645"]},"institutions":[{"id":"https://openalex.org/I148314036","display_name":"Uniformed Services University of the Health Sciences","ror":"https://ror.org/04r3kq386","country_code":"US","type":"education","lineage":["https://openalex.org/I148314036"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patricia L. Theard","raw_affiliation_strings":["Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA","institution_ids":["https://openalex.org/I148314036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074448016","display_name":"Jacob M. Hughes","orcid":"https://orcid.org/0009-0007-6686-5014","observed_orcids":["https://orcid.org/0009-0007-6686-5014"]},"institutions":[{"id":"https://openalex.org/I148314036","display_name":"Uniformed Services University of the Health Sciences","ror":"https://ror.org/04r3kq386","country_code":"US","type":"education","lineage":["https://openalex.org/I148314036"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacob M. Hughes","raw_affiliation_strings":["Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA","institution_ids":["https://openalex.org/I148314036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029613803","display_name":"Amanda J. Linke","orcid":"https://orcid.org/0000-0001-5719-9696","observed_orcids":["https://orcid.org/0000-0001-5719-9696"]},"institutions":[{"id":"https://openalex.org/I148314036","display_name":"Uniformed Services University of the Health Sciences","ror":"https://ror.org/04r3kq386","country_code":"US","type":"education","lineage":["https://openalex.org/I148314036"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amanda J. Linke","raw_affiliation_strings":["Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA","institution_ids":["https://openalex.org/I148314036"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031947555","display_name":"Brianna R. Daley","orcid":"https://orcid.org/0009-0008-3018-9963","observed_orcids":["https://orcid.org/0009-0008-3018-9963"]},"institutions":[{"id":"https://openalex.org/I148314036","display_name":"Uniformed Services University of the Health Sciences","ror":"https://ror.org/04r3kq386","country_code":"US","type":"education","lineage":["https://openalex.org/I148314036"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brianna R. Daley","raw_affiliation_strings":["Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA","institution_ids":["https://openalex.org/I148314036"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051052453","display_name":"Robert L. Kortum","orcid":"https://orcid.org/0000-0002-1634-4882","observed_orcids":["https://orcid.org/0000-0002-1634-4882"]},"institutions":[{"id":"https://openalex.org/I148314036","display_name":"Uniformed Services University of the Health Sciences","ror":"https://ror.org/04r3kq386","country_code":"US","type":"education","lineage":["https://openalex.org/I148314036"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Robert L. Kortum","raw_affiliation_strings":["Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA","institution_ids":["https://openalex.org/I148314036"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5051052453"],"corresponding_institution_ids":["https://openalex.org/I148314036"],"apc_list":{"value":3150,"currency":"USD","value_usd":3150},"apc_paid":{"value":3150,"currency":"USD","value_usd":3150},"fwci":2.4776,"has_fulltext":true,"cited_by_count":14,"citation_normalized_percentile":{"value":0.90764777,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"27","issue":"1","first_page":"108711","last_page":"108711"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.9950000047683716},{"id":"https://openalex.org/keywords/rtk-ras-pathway","display_name":"RTK-RAS pathway","score":0.8130000233650208},{"id":"https://openalex.org/keywords/osimertinib-resistance","display_name":"osimertinib resistance","score":0.9829999804496765},{"id":"https://openalex.org/keywords/egfr-mutant-lung-adenocarcinoma","display_name":"EGFR-mutant lung adenocarcinoma","score":0.9380000233650208},{"id":"https://openalex.org/keywords/shp2-inhibition","display_name":"SHP2 inhibition","score":0.8690000176429749},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.9139999747276306},{"id":"https://openalex.org/keywords/kras-g12c-inhibitors","display_name":"KRAS G12C inhibitors","score":0.8309999704360962},{"id":"https://openalex.org/keywords/adagrasib","display_name":"adagrasib","score":0.9330000281333923},{"id":"https://openalex.org/keywords/sotorasib","display_name":"sotorasib","score":1.0},{"id":"https://openalex.org/keywords/trametinib","display_name":"trametinib","score":0.9710000157356262},{"id":"https://openalex.org/keywords/tipifarnib","display_name":"tipifarnib","score":0.9710000157356262},{"id":"https://openalex.org/keywords/farnesyltransferase-inhibitors","display_name":"farnesyltransferase inhibitors","score":0.7950000166893005},{"id":"https://openalex.org/keywords/targeted-therapy-resistance","display_name":"targeted therapy resistance","score":0.5989999771118164},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.7049999833106995}],"concepts":[{"id":"https://openalex.org/C2777822432","wikidata":"https://www.wikidata.org/wiki/Q216681","display_name":"In situ","level":2,"score":0.6043211221694946},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.5122630000114441},{"id":"https://openalex.org/C57473165","wikidata":"https://www.wikidata.org/wiki/Q7315604","display_name":"Resistance (ecology)","level":2,"score":0.4125220775604248},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33332008123397827},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33060014247894287},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3260759115219116},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.09450912475585938},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":8,"locations":[{"id":"doi:10.1016/j.isci.2023.108711","doi":"https://doi.org/10.1016/j.isci.2023.108711","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.isci.2023.108711","pdf_url":null,"source":{"id":"https://openalex.org/S2898358376","display_name":"iScience","issn_l":"2589-0042","issn":["2589-0042"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310315673","host_organization_name":"Cell Press","host_organization_lineage":["https://openalex.org/P4310315673","https://openalex.org/P4310320990"],"host_organization_lineage_names":["Cell Press","Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"iScience","raw_type":"journal-article"},{"id":"doi:10.1101/2023.01.27.525958","doi":"https://doi.org/10.1101/2023.01.27.525958","is_oa":true,"landing_page_url":"https://doi.org/10.1101/2023.01.27.525958","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2023/02/03/2023.01.27.525958.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},{"id":"doi:10.2139/ssrn.4510603","doi":"https://doi.org/10.2139/ssrn.4510603","is_oa":true,"landing_page_url":"https://doi.org/10.2139/ssrn.4510603","pdf_url":null,"source":{"id":"https://openalex.org/S4210172589","display_name":"SSRN Electronic Journal","issn_l":"1556-5068","issn":["1556-5068"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1318003438","host_organization_name":"RELX Group (Netherlands)","host_organization_lineage":["https://openalex.org/I1318003438"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"posted-content"},{"id":"pmh:oai:pubmedcentral.nih.gov:10788224","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10788224","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10788224/pdf/main.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"iScience","raw_type":"Text"},{"id":"pmid:36747633","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36747633","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"bioRxiv : the preprint server for biology","raw_type":"Preprint"},{"id":"pmid:38226159","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38226159","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"iScience","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9901014","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9901014","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9901014/pdf/nihpp-2023.01.27.525958v3.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:935f01a0ae87470eb58212d48ccf07d4","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/935f01a0ae87470eb58212d48ccf07d4","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"iScience, Vol 27, Iss 1, Pp 108711- (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.isci.2023.108711","doi":"https://doi.org/10.1016/j.isci.2023.108711","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.isci.2023.108711","pdf_url":null,"source":{"id":"https://openalex.org/S2898358376","display_name":"iScience","issn_l":"2589-0042","issn":["2589-0042"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","vabb-shw"],"host_organization":"https://openalex.org/P4310315673","host_organization_name":"Cell Press","host_organization_lineage":["https://openalex.org/P4310315673","https://openalex.org/P4310320990"],"host_organization_lineage_names":["Cell Press","Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"iScience","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[{"id":"https://openalex.org/G397383491","display_name":null,"funder_award_id":"LC180213","funder_id":"https://openalex.org/F4320338273","funder_display_name":"Congressionally Directed Medical Research Programs"},{"id":"https://openalex.org/G9000864537","display_name":"Isoform-specific signaling as a determinant of RAS-driven oncogenesis","funder_award_id":"R01CA255232","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G962880621","display_name":"Preventing Therapeutic Resistance in RAS-mutated Pediatric Cancers","funder_award_id":"R21CA267515","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306078","display_name":"U.S. Department of Defense","ror":"https://ror.org/0447fe631"},{"id":"https://openalex.org/F4320308380","display_name":"Yale University","ror":"https://ror.org/03v76x132"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320332504","display_name":"Uniformed Services University of the Health Sciences","ror":"https://ror.org/04r3kq386"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320338273","display_name":"Congressionally Directed Medical Research Programs","ror":"https://ror.org/03g2zjp07"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4389537586.pdf","grobid_xml":"https://content.openalex.org/works/W4389537586.grobid-xml"},"referenced_works_count":55,"referenced_works":["https://openalex.org/W1579152647","https://openalex.org/W1903208781","https://openalex.org/W1973260880","https://openalex.org/W2043693109","https://openalex.org/W2050211354","https://openalex.org/W2062410054","https://openalex.org/W2062964246","https://openalex.org/W2062983115","https://openalex.org/W2071006154","https://openalex.org/W2079187345","https://openalex.org/W2086936470","https://openalex.org/W2091334045","https://openalex.org/W2092145769","https://openalex.org/W2117784514","https://openalex.org/W2121993228","https://openalex.org/W2123431502","https://openalex.org/W2136076059","https://openalex.org/W2151457918","https://openalex.org/W2184779060","https://openalex.org/W2338377057","https://openalex.org/W2504472048","https://openalex.org/W2551592805","https://openalex.org/W2736453204","https://openalex.org/W2738886067","https://openalex.org/W2770828094","https://openalex.org/W2772606138","https://openalex.org/W2773830451","https://openalex.org/W2785187242","https://openalex.org/W2809980410","https://openalex.org/W2885289995","https://openalex.org/W2887730046","https://openalex.org/W2891277144","https://openalex.org/W2901243719","https://openalex.org/W2910264472","https://openalex.org/W2917986762","https://openalex.org/W2943767349","https://openalex.org/W2944288619","https://openalex.org/W2970960552","https://openalex.org/W2974668768","https://openalex.org/W2990041408","https://openalex.org/W3000285141","https://openalex.org/W3017413818","https://openalex.org/W3022422196","https://openalex.org/W3084211591","https://openalex.org/W3127496990","https://openalex.org/W3142010099","https://openalex.org/W3159275491","https://openalex.org/W3183139760","https://openalex.org/W4205686435","https://openalex.org/W4254922568","https://openalex.org/W4281630536","https://openalex.org/W4311677159","https://openalex.org/W4315927809","https://openalex.org/W4386531447","https://openalex.org/W6856818344"],"related_works":["https://openalex.org/W2992271344","https://openalex.org/W4393095426","https://openalex.org/W4416655751","https://openalex.org/W7203677046","https://openalex.org/W4285594801","https://openalex.org/W3033316579","https://openalex.org/W4367603888","https://openalex.org/W2995877501","https://openalex.org/W3085529787","https://openalex.org/W2741767006"],"abstract_inverted_index":{"Abstract":[0],"Intrinsic":[1],"and":[2,180,186,209],"acquired":[3,31,55,77,95,204,224,245],"resistance":[4,32,44,56,64,78,97,121,167,200,205,229,247],"limit":[5],"the":[6,148,175,182,187,195,215,242],"window":[7],"of":[8,104,125,143,197,244,253],"effectiveness":[9],"for":[10,213],"oncogene-targeted":[11],"cancer":[12],"therapies.":[13,61],"Preclinical":[14],"studies":[15,193],"that":[16,53,94,130],"identify":[17],"synergistic":[18,219],"combinations":[19,221],"enhance":[20],"therapeutic":[21],"efficacy":[22],"to":[23,29,57,114,138,156,165,168,202,206,217,230,261],"target":[24,223],"intrinsic":[25],"resistance,":[26],"however,":[27],"methods":[28],"study":[30],"in":[33,42,48,65,198,237],"cell":[34,84],"culture":[35,51],"are":[36],"lacking.":[37],"Here,":[38],"we":[39,75],"describe":[40],"an":[41],"situ":[43,199,238],"assay":[45],"(ISRA),":[46],"performed":[47],"a":[49,72,211],"96-well":[50],"format,":[52],"models":[54],"RTK/RAS":[58,170,231],"pathway":[59,171,232],"targeted":[60,172,207],"Using":[62],"osimertinib":[63,89,96,246,262],"EGFR":[66],"-mutated":[67],"lung":[68],"adenocarcinoma":[69],"(LUAD)":[70],"as":[71],"model":[73,166,203],"system,":[74],"show":[76,93,251],"can":[79,98,222,234],"be":[80,99,235],"reliably":[81],"modeled":[82,236],"across":[83],"lines":[85],"with":[86],"objectively":[87,159],"defined":[88,160],"doses.":[90],"We":[91],"further":[92],"significantly":[100],"delayed":[101],"by":[102],"inhibition":[103,142],"proximal":[105,144],"RTK":[106,132,145],"signaling":[107,146],"using":[108,147],"two":[109],"distinct":[110],"SHP2":[111,149,239,256],"inhibitors.":[112],"Similar":[113],"patient":[115],"populations,":[116],"isolated":[117],"osimertinib-resistant":[118,249],"populations":[119,155,250,260],"showed":[120],"via":[122],"enhanced":[123],"activation":[124],"multiple":[126,254],"parallel":[127],"RTKs":[128,255],"so":[129],"individual":[131],"inhibitors":[133,178,240,257],"did":[134],"not":[135],"re-sensitize":[136,258],"cells":[137],"osimertinib.":[139,157],"In":[140],"contrast,":[141],"inhibitor":[150,184,190],"RMC-4550":[151],"both":[152],"re-sensitized":[153],"resistant":[154,259],"Similar,":[158],"drug":[161,220,225],"doses":[162],"were":[163],"used":[164],"additional":[169],"therapies":[173,208],"including":[174],"KRAS":[176],"G12C":[177],"adagrasib":[179],"sotorasib,":[181],"MEK":[183],"trametinib,":[185],"farnesyl":[188],"transferase":[189],"tipifarnib.":[191],"These":[192],"highlight":[194],"tractability":[196],"assays":[201],"provide":[210],"framework":[212],"assessing":[214],"extent":[216],"which":[218],"resistance.":[226],"Highlights":[227],"Acquired":[228],"members":[233],"reduce":[241],"development":[243],"Isolated":[248],"hyperactivation":[252],"treatment":[263]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-12-12T00:00:00"}